ANGELA ELIZABETH SANDRE DO NPI 1588601157

NPI Details

Angela Elizabeth Sandre, DO is a medical oncology internal medicine in Des Moines, IA with 26 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Angela Elizabeth Sandre, DO NPI is 1588601157. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: DES MOINES UNIVERSITY OF OSTEOPATHIC MEDICINE AND HEALTH SCIENCES
Graduation Year:2000

The provider's business location address is:

411 LAUREL ST STE A300
DES MOINES, IA
ZIP 50314-030
Phone: (515) 282-2921
Fax: (515) 643-8819

The NPI 1588601157 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg (HCPCS:Q5112)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Folic acid level, serum (HCPCS:82746)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Uric acid level, blood (HCPCS:84550)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Magnesium level (HCPCS:83735)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Unclassified drugs (HCPCS:J3490)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Phosphate level (HCPCS:84100)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Stool analysis for blood, by peroxidase activity (HCPCS:82272)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)

The enumeration date for this NPI number is 6/1/2006 and was last updated on 2/5/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: